4j15: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[4j15]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4J15 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4J15 FirstGlance]. <br> | <table><tr><td colspan='2'>[[4j15]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4J15 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4J15 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.24Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4j15 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4j15 OCA], [https://pdbe.org/4j15 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4j15 RCSB], [https://www.ebi.ac.uk/pdbsum/4j15 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4j15 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4j15 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4j15 OCA], [https://pdbe.org/4j15 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4j15 RCSB], [https://www.ebi.ac.uk/pdbsum/4j15 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4j15 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
Latest revision as of 17:18, 8 November 2023
Crystal structure of human cytosolic aspartyl-tRNA synthetase, a component of multi-tRNA synthetase complexCrystal structure of human cytosolic aspartyl-tRNA synthetase, a component of multi-tRNA synthetase complex
Structural highlights
FunctionSYDC_HUMAN Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Publication Abstract from PubMedHuman cytosolic aspartyl-tRNA synthetase (DRS) catalyzes the attachment of the amino acid aspartic acid to its cognate tRNA and it is a component of the multi-tRNA synthetase complex (MSC) which has been known to be involved in unexpected signaling pathways. Here, we report the crystal structure of DRS at 2.25 A resolution. DRS is a homodimer with a dimer interface 3,750.5 A2 which comprises of 16.6% of the monomeric surface area. Our structure reveals the C-terminal end of the N-helix which is considered as a unique addition in DRS, and its conformation further supports the switching model of the N-helix for the transfer of tRNAAsp to elongation factor 1alpha. From our analyses of the crystal structure and post-translational modification of DRS, we suggest that the phosphorylation of Ser146 provokes the separation of DRS from the MSC and provides the binding site for an interaction partner with unforeseen functions. (c) Proteins 2013;. (c) 2013 Wiley Periodicals, Inc. Crystal structure of human cytosolic aspartyl-tRNA synthetase, a component of multi-tRNA synthetase complex.,Kim KR, Park SH, Kim HS, Rhee KH, Kim BG, Kim DG, Park MS, Kim HJ, Kim S, Han BW Proteins. 2013 Apr 23. doi: 10.1002/prot.24306. PMID:23609930[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||||